Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity
about
Theoretical Approaches to Lentiviral Mediated Neurotrophin Delivery in Potential Treatments of Parkinson's DiseaseManganese exposure induces α-synuclein aggregation in the frontal cortex of non-human primatesPrediction of new drug indications based on clinical data and network modularity.Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body DementiaInsulin action in brain regulates systemic metabolism and brain function.CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer's DiseaseAnalyzing microarray data of Alzheimer's using cluster analysis to identify the biomarker genes.Mechanisms of ceramide-mediated neurodegeneration.Differential Contributions of Alcohol and the Nicotine-Derived Nitrosamine Ketone (NNK) to Insulin and Insulin-Like Growth Factor Resistance in the Adolescent Rat Brain.Efficient Expression of Igf-1 from Lentiviral Vectors Protects In Vitro but Does Not Mediate Behavioral Recovery of a Parkinsonian Lesion in Rats.Meta-type analysis of dopaminergic effects on gene expression in the neuroendocrine brain of female goldfish.Interleukin-10 Protection against Lipopolysaccharide-Induced Neuro-Inflammation and Neurotoxicity in Ventral Mesencephalic Cultures.Attenuation of insulin signalling contributes to FSN-1-mediated regulation of synapse development.Relationships between diabetes and cognitive impairmentAberrant Adult Neurogenesis in the Subventricular Zone-Rostral Migratory Stream-Olfactory Bulb System Following Subchronic Manganese ExposureProinsulin: from hormonal precursor to neuroprotective factorLiver mitochondrial dysfunction is reverted by insulin-like growth factor II (IGF-II) in aging rats.Insulin-Like Growth Factor-II/Cation-Independent Mannose 6-Phosphate Receptor in Neurodegenerative Diseases.The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction.Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.α-Synuclein overexpression enhances manganese-induced neurotoxicity through the NF-κB-mediated pathway.Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders.Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at 'Type 3 Diabetes', Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments.Mitochondrial Chaperones in the Brain: Safeguarding Brain Health and Metabolism?Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function.
P2860
Q26746174-EDB1305B-A16C-4130-9733-AC0974AAFEBAQ28397442-44460EFD-F445-43FE-BDFE-16421B307A19Q31133470-EF86085B-05EB-499E-9087-8325F158A866Q33543381-9A03E39D-1481-4E94-8CB4-1CABB165DA78Q33708946-2B940156-4FD8-4179-9DCD-3D492FF39367Q33789365-497723BC-4680-416A-9214-F9390B77CF65Q33896118-AA11BA3E-6D70-4F13-8550-BB5B368B9D41Q34223702-B323C381-7B0F-4855-BE5B-A025721AC026Q35997878-56497BF1-6E78-4662-8C64-3C81C1993F51Q36170557-2578ED29-B39B-4293-BF8D-BF8AC59F0ECAQ36294787-EAB5CE16-B889-4223-B280-EB176E60A238Q36365863-C4ED3B3E-BDCF-480A-BFF4-C42A162DED9DQ36512406-EA9D5DE3-31F7-40B7-8A79-B4E17D4A877BQ36923841-9275E7C1-36F2-4F7C-AD37-16B726FD62F3Q37162219-1A369966-CF33-4D3B-8C5C-503D7E318B1EQ37228262-94B6BF64-A9AA-4438-BEE7-0C47DCE8534AQ37939111-44192BDB-5E61-4EF3-A217-D60DCC7A78CDQ38264375-E7C0025A-3A75-40F5-BA15-698AFA4784B8Q38780921-5EEFB821-3976-4DE7-85E3-E6BBD64BCA53Q38809233-619EC82B-FBF7-45CC-8443-993AE2BC8261Q39042377-DAF6E4C9-FE36-431C-9810-E014C717E31CQ39574142-CAA68334-5448-477C-93F6-E28C8336C90FQ46309597-B213CA1B-B75C-4CCE-AC9C-DA96F93D7E70Q47835103-799432EC-F735-4347-9F93-641F3F205882Q55266969-349E14A5-D24B-4741-BA31-4A78D3A1BF6DQ55283805-BE27874A-23D0-4B46-B0DC-F505D60CDCEEQ55515162-2A1778E1-8E78-4B08-9CDF-74A002A54955
P2860
Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Brain insulin-like growth fact ...... ole of manganese neurotoxicity
@ast
Brain insulin-like growth fact ...... ole of manganese neurotoxicity
@en
Brain insulin-like growth fact ...... ole of manganese neurotoxicity
@nl
type
label
Brain insulin-like growth fact ...... ole of manganese neurotoxicity
@ast
Brain insulin-like growth fact ...... ole of manganese neurotoxicity
@en
Brain insulin-like growth fact ...... ole of manganese neurotoxicity
@nl
prefLabel
Brain insulin-like growth fact ...... ole of manganese neurotoxicity
@ast
Brain insulin-like growth fact ...... ole of manganese neurotoxicity
@en
Brain insulin-like growth fact ...... ole of manganese neurotoxicity
@nl
P2093
P2860
P921
P3181
P1476
Brain insulin-like growth fact ...... ole of manganese neurotoxicity
@en
P2093
Matthew Dong
Suzanne M de la Monte
P2860
P304
P3181
P356
10.3233/JAD-2009-0995
10.3410/F.1161757.623357
P407
P577
2009-01-01T00:00:00Z